Hydrogen sulfide (H2S) treatment significantly reduced PM-induced emphysema and airway inflammation by inhibiting ferroptosis in vivo and in vitro through NRF2-PPAR pathway, while H2S treatment did not reverse lung injury and ferroptosis in NRF2 knockout mice (95, 96). The gene discussed is NFE2L2; the disease is pulmonary emphysema.